Science and Innovation in the 118th Congress
The United States faces a broad array of challenges, from intense competition in science and technology abroad, to the need for safe and resilient critical systems at home.
To be sure, narrowly split control of Congress adds to the complexity of addressing these challenges. But even in this situation, the 118th Congress can still create opportunities for bipartisan action to bolster American economic security, national security, and health. There are many national goals on which the parties agree. These include:
- Stronger American science and innovation
- Reliable, cleaner domestic energy
- An American society that’s safe from threat of pandemics
- Resilient, productive American agriculture
Even if there are some areas in which policy differences persist, there are many where action is possible.
To help seed the ground for bipartisan progress, we have assembled a wide-ranging menu of policy ideas on a range of critical topics.
Where do these ideas come from?
This menu of policy ideas, organized by theme, was primarily generated over the past three years through crowdsourced outreach by the Day One Project, and refined with the help of the Day One Project team to transform promising ideas into actionable policy proposals.
We have added a few additional ideas of our own, but the majority are derived from Day One Policy Memos authored by experts, scholars, and policy entrepreneurs from an array of backgrounds. Click on the links found throughout this report to access the source memos, which include rationales and plans of action for policy implementation.
This is a bipartisan, commonsense measure to reauthorize the Technology Modernization Fund (TMF) before it expires in September 2026.
Many states are introducing AI policies and task forces, but lack the “AI-native” personnel to build and maintain initiatives. To address this in the short term, states should establish AI Resilience Cohorts to embed early-career technologists in key offices to support state AI initiatives. Right now, Virginia and New Jersey have the opportunity to take […]
We sat down with biomedical research pioneer Lee Hood to talk moonshots, metascience in medicine, and the Human Phenome Initiative.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.